Your session is about to expire
← Back to Search
amnion-chorion membrane for Gum Disease
N/A
Waitlist Available
Research Sponsored by Harvard Medical School
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if a special membrane made from donated tissue can help wounds in the mouth heal better after gum graft surgery. It aims to reduce pain and complications for patients undergoing this procedure.
Eligible Conditions
- Gum Disease
- Infections
- Postoperative Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Postoperative pain as evaluated by subjects using the Visual Analogue Scale
Secondary study objectives
Pain Catastrophizing Scale (PCS)
Pain management (medication usage)
Patient satisfaction as evaluated by Visual Analogue Scale
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Allograft and SuturesExperimental Treatment1 Intervention
Patients assigned to Allograft and Sutures will have allograft placed and secured with sutures on the donor site.
Group II: SuturesActive Control1 Intervention
Patients assigned to Sutures group will not have the allograft placed on the donor site. One current clinical standard of practice is to place sutures on donor site. Patients assigned to Sutures group will have sutures placed on donor site.
Find a Location
Who is running the clinical trial?
Harvard Medical SchoolLead Sponsor
29 Previous Clinical Trials
40,649 Total Patients Enrolled
Harvard Medical School (HMS and HSDM)Lead Sponsor
203 Previous Clinical Trials
1,316,449 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger